More Oxygenta Pharmaceutical Limited news
Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Apr 28 2025

Apr 28, 2025 at 9:59 AM UTC · Issued by Oxygenta Pharmaceutical Limited

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Vishram Chawda

View Attachment